{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T13:42:06Z","timestamp":1648906926013},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[1992,1]]},"DOI":"10.1007\/bf01709942","type":"journal-article","created":{"date-parts":[[2005,6,11]],"date-time":"2005-06-11T17:56:01Z","timestamp":1118512561000},"page":"S3-S8","source":"Crossref","is-referenced-by-count":6,"title":["In vitro activity of cefodizime"],"prefix":"10.1007","volume":"20","author":[{"given":"H.","family":"Knothe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. M.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01709942_CR1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/AAC.19.2.248","volume":"19","author":"J. E. Brown","year":"1981","unstructured":"Brown, J. E., Del Bene, V. E., Collins, C. D. In vitro activity of N-formimidoyl thienamycin, moxalactam and other new beta-lactam agents againstBacteroides fragilis: contribution of beta-lactamase to resistance. Antimicrob. Agents Chemother. 19 (1981) 248\u2013252.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01709942_CR2","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1128\/AAC.14.3.322","volume":"14","author":"K. P. Fu","year":"1978","unstructured":"Fu, K. P., Neu, H. C. Beta-lactamase stability of HR 756, a novel cephalosporin, compared to that of cefuroxime and cefoxitin. Antimicrob. Agents Chemother. 14 (1978) 322\u2013326.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01709942_CR3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.7164\/antibiotics.32.909","volume":"32","author":"K. P. Fu","year":"1979","unstructured":"Fu, K. P., Neu, H. C. The comparative \u03b2-lactamase resistance and inhibitory activity of 1-oxa cephalosporin, cefoxitin and cefotaxime. J. Antibiot. 32 (1979) 909\u2013914.","journal-title":"J. Antibiot."},{"key":"BF01709942_CR4","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.7164\/antibiotics.32.1319","volume":"32","author":"M. Nishida","year":"1979","unstructured":"Nishida, M., Kamimura, T., Okada, N., Matsumoto, Y., Mine, Y., Murakawa, T., Goto, S., Kuwahara, S. Comparison of antibacterial activity of a new cephalosporin, ceftizoxime (FK 749) with other cephalosporin antibiotics. J. Antibiot. 32 (1979) 1319\u20131327.","journal-title":"J. Antibiot."},{"key":"BF01709942_CR5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/AAC.18.2.292","volume":"18","author":"K. Shannon","year":"1980","unstructured":"Shannon, K., King, A., Warren, C., Phillips, I. In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases. Antimicrob. Agents Chemother. 18 (1980) 292\u2013298.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01709942_CR6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/AAC.20.6.760","volume":"20","author":"R. N. Jones","year":"1981","unstructured":"Jones, R. N., Barry, A. L., Thornsberry, C., Wilson, H. W. In vitro antimicrobial activity evaluation of cefodizime (HR 221), a new semisynthetic cephalosporin. Antimicrob. Agents Chemother. 20 (1981) 760\u2013768.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01709942_CR7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7164\/antibiotics.40.29","volume":"40","author":"J. Blumbach","year":"1987","unstructured":"Blumbach, J., D\u00fcrckheimer, W., Ehlers, E., Fleischmann, K., Klesel, N., Limbert, M., Mencke, B., Reden, J., Scheunemann, K. H., Schrinner, E., Seibert, G., Wieduwilt, M., Worm, M. Cefodizime, an aminothiazolyl cephalosporin. V. Synthesis and structure-activity relationships in the cefodizime series. J. Antibiot. 40 (1987) 29\u201342.","journal-title":"J. Antibiot."},{"key":"BF01709942_CR8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.7164\/antibiotics.37.901","volume":"37","author":"N. Klesel","year":"1984","unstructured":"Klesel, N., Limbert, M., Seeger, K., Seibert, G., Winkler, I., Schrinner, E. Cefodizime, an aminothiazolyl cephalosporin. II. Comparative studies on the pharmacokinetic behavior in laboratory animals. J. Antibiot. 37 (1984) 901\u2013909.","journal-title":"J. Antibiot."},{"key":"BF01709942_CR9","first-page":"18","volume":"10","author":"E. E. Dagrosa","year":"1987","unstructured":"Dagrosa, E. E., Hajd\u00fa, P., Malerczyk, V., de Looze, S., Seeger, K., Gr\u00f6tsch, H. Dose linearity and other pharmacokinetics of cefodizime after single-dose intravenous administration. Clin. Ther. 10 (1987) 18\u201331.","journal-title":"Clin. Ther."},{"issue":"S-5","key":"BF01709942_CR10","first-page":"1","volume":"36","author":"A. Hyodo","year":"1988","unstructured":"Hyodo, A., Higashitani, F., Mitsuhashi, S., Inoue, M. In vitro andin vivo antibacterial activity of cefodizime. Chemotherapy 36 (S-5) (1988) 1\u201324.","journal-title":"Chemotherapy"},{"key":"BF01709942_CR11","unstructured":"Stille, W., Spieler, S.: Antibacterial activity of cefodizime (HR 221). Proceedings of the 14th International Congress of Chemotherapy, Antimicrobial Section 2. Recent Adv. Chemother. (1985) 923\u2013924."},{"key":"BF01709942_CR12","doi-asserted-by":"crossref","first-page":"892","DOI":"10.7164\/antibiotics.37.892","volume":"37","author":"M. Limbert","year":"1984","unstructured":"Limbert, M., Klesel, N., Seeger, K., Seibert, G., Winkler, I., Schrinner, E. Cefodizime, an aminothiazolyl cephalosporin. I.In vitro activity. J. Antibiot. 37 (1984) 892\u2013900.","journal-title":"J. Antibiot."},{"key":"BF01709942_CR13","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.7164\/antibiotics.37.1294","volume":"37","author":"K. Kasai","year":"1984","unstructured":"Kasai, K., Tsuji, A., Miyazaki, S., Goto, S., Fujimoto, K., Masuyoshi, S., Arai, S. In vitro antibacterial activity and \u03b2-lactamase stability of cefodizime, a new cephalosporin antibiotic. Jpn. J. Antibiot. 37 (1984) 1294\u20131305.","journal-title":"Jpn. J. Antibiot."},{"key":"BF01709942_CR14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jac\/25.3.413","volume":"25","author":"F. P. V. Maesen","year":"1990","unstructured":"Maesen, F. P. V., Davies, B. I., van den Bergh, J. J. A. M., Gubbelmans, H. L. L., Meek, J. C. E., Geraedts, W. H. Cefodizime and cefotaxime in acute exacerbations of chronic bronchitis: a randomized double-blind prospective study in 180 patients. J. Antimicrob. Chemother. 25 (1990) 413\u2013422.","journal-title":"J. Antimicrob. Chemother."},{"key":"BF01709942_CR15","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/AAC.32.4.426","volume":"32","author":"A. H. Willigen van der","year":"1988","unstructured":"van der Willigen, A. H., Wagenvoort, J. H. T., Schalla, W. O., Knapp, J. S., Boot, J. M., Heeres-Weststrate, P. L., Michel, M. F., van Klingeren, B., Stolz, E. Randomized comparative study of 0.5 and 1 g of cefodizime (HR 221) versus 1 g of cefotaxime for acute uncomplicated urogenital gonorrhea. Antimicrob. Agents Chemother. 32 (1988) 426\u2013429.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01709942_CR16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1128\/AAC.23.3.477","volume":"23","author":"M. Y. Khan","year":"1983","unstructured":"Khan, M. Y., Gruninger, R. P., Nelson, S. M., Obaid, S. R. Comparativein vitro activity of cefodizime, ceftazidime, aztreonam, and other selected antimicrobial agents againstNeisseria gonorrheae. Antimicrob. Agents Chemother. 23 (1983) 477\u2013478.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01709942_CR17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jac\/19.5.701","volume":"19","author":"A. Pascual","year":"1987","unstructured":"Pascual, A., Borobio, V., Garcia-Iglesias, M. C., Perea, E. J. Comparativein-vitro activity of cefodizime, cefpirome, carumonam and RU-28965 with other antimicrobials against anaerobes. Antimicrob. Agents Chemother. 19 (1987) 701\u2013703.","journal-title":"Antimicrob. Agents Chemother."},{"issue":"S-5","key":"BF01709942_CR18","first-page":"77","volume":"36","author":"K. Watanabe","year":"1988","unstructured":"Watanabe, K., Sawa, K., Sawamura, H., Yamaoka, K., Aoki, M., Kato, N., Ueno, K. In vitro andin vivo activity of cefodizime against anaerobic bacteria. Chemotherapy 36 (S-5) (1988) 77\u201394.","journal-title":"Chemotherapy"},{"key":"BF01709942_CR19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF01640880","volume":"10","author":"R. N. Jones","year":"1982","unstructured":"Jones, R. N., Wilson, H. W. Comparative beta-lactamase hydrolysis of and inhibition by 7-aminothiazolyl alpha-methoxyimino cephalosporins. Infection 10 (1982) 303\u2013304.","journal-title":"Infection"},{"key":"BF01709942_CR20","volume-title":"Studies on the penetration properties of HR 221 through the cell wall of gram-negative bacteria","author":"G. Seibert","year":"1982","unstructured":"Seibert, G. Studies on the penetration properties of HR 221 through the cell wall of gram-negative bacteria. Hoechst AG, Frankfurt 1982, data on cefodizime submission file."},{"key":"BF01709942_CR21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/AAC.23.6.907","volume":"23","author":"B. E. Scully","year":"1983","unstructured":"Scully, B. E., Jules, K., Neu, H. C. In vitro activity and \u03b2-lactamase stability of cefodizime, an aminothiazolyl iminomethoxy cephalosporin. Antimicrob. Agents Chemother. 23 (1983) 907\u2013913.","journal-title":"Antimicrob. Agents Chemother."},{"key":"BF01709942_CR22","unstructured":"Shah, P. M.: Bactericidal activity of cefodizime under conditions simulating serum pharmacokinetic parameters. Proceedings of the 14th International Congress of Chemotherapy, Antimicrobial Section 2. Recent Adv. Chemother., Kyoto (1985) 935\u2013936."}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01709942.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01709942\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01709942","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T08:47:39Z","timestamp":1557305259000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01709942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,1]]},"references-count":22,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1992,1]]}},"alternative-id":["BF01709942"],"URL":"https:\/\/doi.org\/10.1007\/bf01709942","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,1]]}}}